TICKERNERD
Menu
NUSNUSConsumer Defensive · Household & Personal Products

NUS Stock Forecast: Nu Skin Enterprises, Inc. Price Predictions for 2026-2027

Last close, 11 Sept 2026
$4.85
−0.61% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 64 of 100 as at 12 Sept 2026 — in the upper half.

Market cap
$236.1M
Ticker Nerd rank
64 / 100
Median analyst target
$13
Analysts covering
0
Revenue$320.1M−17.1% y/y
Operating income$19.6M
Net income−$249.8M
Free cash flow$5.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+3.2%
1M
+0.8%
YTD
−48.1%
1Y
−57.1%
From 52W high
−60.9%
From 52W low
+6.1%
$5
$12
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

NUS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Nu Skin Enterprises, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026
64 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
99
Issuance
96
Accruals
95
Size
65
Quality
55
Volatility
41
Revisions
32
Growth
25
Momentum
12

Value (99): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Momentum (12): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

NUS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on NUS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$4$6$8$10$12$14Oct 25Jan 26Apr 26Jul 26NUSHigh $13Median $13Low $13

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Recent analyst actionsNewest first
DateFirmActionRatingTarget
20 Dec 2024DA DavidsonMaintainsNeutral$11 → $7.00
22 Oct 2024CitigroupMaintainsNeutral—
12 Aug 2024DA DavidsonMaintainsNeutral—
9 Aug 2024CitigroupMaintainsNeutral—
9 May 2024DA DavidsonMaintainsNeutral—
5 Jan 2024DA DavidsonMaintainsNeutral—
16 Oct 2023StifelMaintainsHold—
29 Sept 2023CitigroupMaintainsNeutral—
3 Aug 2023DA DavidsonReiteratesNeutral—
2 Aug 2023StifelMaintainsHold—
19 May 2023DA DavidsonReiteratesNeutral—
1 Mar 2023CitigroupMaintainsNeutral—
16 Feb 2023DA DavidsonMaintainsNeutral—
31 Jan 2023JefferiesDowngradeHold—
23 Nov 2022DA DavidsonMaintainsNeutral—
5 Oct 2022CitigroupMaintainsNeutral—
23 Aug 2022DA DavidsonMaintainsNeutral—
8 Aug 2022CitigroupMaintainsNeutral—
5 May 2022DA DavidsonMaintainsNeutral—
17 Feb 2022DA DavidsonMaintainsNeutral—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NUS appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

NUS vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Nu Skin Enterprises, Inc. returned −57.1% against +17.5% for the S&P 500, dividends included.

NUS vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120Oct 25Jan 26Apr 26Jul 26NUSS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

NUS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−18.0%
Analysts raising
0
Analysts cutting
1
Fundamentals

Nu Skin Enterprises, Inc. (NUS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
4.8×

Cheaper than 66% of US stocks

Price / sales
0.2×

Cheaper than 94% of US stocks

Price / book
0.4×

Cheaper than 86% of US stocks

EV / EBITDA
2.8×

Cheaper than 56% of US stocks

Growth & margins
Revenue growth (YoY)
−17.1%

Higher than 12% of US stocks

Earnings growth (YoY)
−17.1%

Higher than 22% of US stocks

Gross margin
68.2%

Higher than 81% of US stocks

Operating margin
6.1%

Higher than 57% of US stocks

Net margin
−15.7%

Higher than 17% of US stocks

Returns & dividend
Return on equity
−32.5%

Higher than 26% of US stocks

Return on assets
3.4%

Higher than 68% of US stocks

Dividend yield
5.0%

Higher than 83% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Nu Skin Enterprises, Inc. (NUS) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Nu Skin Enterprises, Inc. has a market value of $236.1M and an enterprise value of $332.8M.

  • Revenue in the twelve months to 30 June 2026: $1.4B. The latest quarter shrank 17.1% year on year.

  • Net income over the same four quarters: −$216.4M, a −15.7% net margin.

  • Diluted earnings per share, trailing twelve months: $−4.47.

  • Free cash flow in the twelve months to 30 June 2026: $10.8M.

  • Nu Skin Enterprises, Inc. spent $20.0M on share buybacks and $11.7M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 48.7M.

  • Trailing P/E: 4.8×; forward P/E: 4.2× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 4.95%, paying out 22% of earnings.

  • Nu Skin Enterprises, Inc. employs 2,800 people — $491K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 13 Sept 2026

Data provided by Twelve Data

Peers

NUS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHousehold & Personal Products
CompanyMarket capTKN rank
NUSNu Skin Enterprises, Inc.$236.1M
64
ACUAcme United Corp.$232.8M
99
WALDWaldencast plc$171.3M
55
MAGNMagnera Corp.$416.5M
43
HNSTThe Honest Co., Inc.$608.5M
83
HELEHelen of Troy Ltd.$623.5M
79
SKINSkinhealth Systems, Inc.$89.4M
76

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Nu Skin Enterprises, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest NUS news & analysis

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

Business Wire · 3 Sept 2026positive

Nu Skin Enterprises has been ranked the world's No. 1 company for beauty and wellness device systems by Euromonitor International for the third consecutive year. The company's CEO described the recognition as validation of its long-term vision and commitment to innovation.

Why it matters — This external recognition of its device systems underscores Nu Skin's market leadership and brand standing in the beauty and wellness category.

Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26

Newsfile Corp · 11 Aug 2026neutral

Stonegate Capital Partners updated its coverage on NU Skin Enterprises Inc. after the company reported revenue of $320.1 million, adjusted net income of $10.0 million, and adjusted EPS of $0.20 for 2Q26.

Why it matters — The update provides NUS watchers with fresh analyst attention and reported financial figures for the second quarter of 2026.

Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y

Zacks Investment Research · 11 Aug 2026negative

Nu Skin Enterprises reported second-quarter results that met analyst estimates, though revenues fell 17.1% year-over-year and EPS declined 53.5%. The company also lowered its 2026 revenue and adjusted EPS outlooks.

Why it matters — Nu Skin watchers would care because the steep year-over-year revenue and earnings declines, along with the reduced 2026 guidance, signal sustained pressure on the company's performance and future expectations.

Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript

Seeking Alpha · 11 Aug 2026neutral

Nu Skin Enterprises, Inc. published its Q2 2026 earnings call transcript on Seeking Alpha, covering the company's second-quarter results and management commentary.

Why it matters — Investors following Nu Skin can review management's discussion of the company's latest quarterly performance directly from the call.

Nu Skin Enterprises Q2 Earnings Call Highlights

MarketBeat · 11 Aug 2026neutral

Nu Skin Enterprises reported second-quarter revenue of $320.1 million and adjusted earnings per share of $0.20, while continuing the rollout of its Prysm iO wellness platform and pursuing cost and margin initiatives.

Why it matters — The report provides an update on Nu Skin's recent financial performance and the progress of its strategic wellness-platform rollout and margin efforts, which matter to shareholders tracking the company's execution.

FAQ

Frequently asked questions about NUS stock

How does Ticker Nerd's model rank NUS?

As at 12 Sept 2026, Nu Skin Enterprises, Inc. ranks 64 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (99 of 100).

What is the NUS stock forecast for 2030?

No analyst covering Nu Skin Enterprises, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NUS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $13 to $13 over the next 12 months.

How has NUS stock performed over the past year?

Nu Skin Enterprises, Inc. returned -57.1% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Nu Skin Enterprises, Inc. do?

Nu Skin Enterprises Inc. Class A is a consumer health and personal care company that develops and distributes beauty and wellness products worldwide.

What is the latest news on NUS?

The most recent item we track (Business Wire, 3 Sept 2026): "Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year". Nu Skin Enterprises has been ranked the world's No. 1 company for beauty and wellness device systems by Euromonitor International for the third consecutive year. The company's CEO described the recognition as validation of its long-term vision and commitment to innovation.

Company

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises Inc. Class A is a consumer health and personal care company that develops and distributes beauty and wellness products worldwide. The company offers a broad portfolio that includes skin care systems and devices, cosmetics, nutritional supplements, weight-management products, and other personal care solutions under brands such as Nu Skin, Pharmanex, and ageLOC. Its business is centered on direct selling and person-to-person marketing, supported by digital tools and a network of independent distributors. Nu Skin serves customers across multiple international markets, with a focus on beauty, anti-aging, and wellness categories. The company plays a role in the global consumer products market by combining product development, brand marketing, and distributed sales channels to reach households and individual consumers.

CEO Mr. Ryan S. Napierski · 2,800 employees · United States · https://www.nuskin.com